Generic Name and Formulations:
Salicylic acid 17%; in flexible collodion; liq.
McNeil Consumer Healthcare
- Gefitinib Continuation Therapy May Be Effective in NSCLC Post-Progression
- Medical School Student Loans: Were They Worth It?
- 3 Strategies to Manage Your Student Loan Debt After Medical School
- H. pylori Eradication Options for Peptic Ulcer Disease
- Renal Cell Carcinoma Treatment Regimens
- FDA-Approved Breast Cancer Drug Treatments
Indications for WART-OFF:
Common and plantar warts.
Adults and Children:
Wash and dry affected area. Apply 1 drop at a time and cover each wart; repeat once or twice daily for up to 12 weeks.
Not for use on moles, birthmarks; facial, anogenital, or unusual warts with hair growth; irritated or infected skin. Avoid eyes, mucous membranes, normal skin. Product is flammable. Impaired circulation (e.g., diabetes).
Liq—0.45oz (w. applicator)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Despite Promising Trial Results, Skeptics Raise Red Flags About Anlotinib's Efficacy in Heavily Treated NSCLC
- Higher Risk of MGUS in Relatives of Patients With Multiple Myeloma Confirmed
- Brentuximab Vedotin Combo Active in Older Patients With Hodgkin Lymphoma
- Prostate Cancer Drug Resistance Mediated by Epigenetic Changes
- Nilotinib and Dasatinib Confer Similar Outcomes for Chronic-Phase CML